Sections
You are here: Home > Services > QB3 Garage@UCSF > Garage@UCSF Tenants
Contact Us

For entrepreneurs:

Douglas Crawford, Ph.D.

Associate Executive Director

douglas.crawford@ucsf.edu

(415) 514-4408

For industry:

Tracy Saxton, Ph.D.

Industrial Affairs Manager

tracy.saxton@ucsf.edu

(415) 514-9767

For clinicians:

Marc Shuman, M.D.

Clinical Director

shuman@medicine.ucsf.edu

(415) 476-2125

 
IN THE PRESS

  • The University of California, San Francisco, opens a special brand of incubator.

    Nature
    by Monya Baker
    November, 2006

  • California incubator hopes to revive "innovation garage" concept

    SmallTimes
    by David Morrill September26, 2006

  • QB3 "Garage" for biotech start-ups offers look inside

    UCSF News Services
    by Wallace Ravven
    September 21, 2006

  • Biotech babies born in 'Garage'

    San Francisco Business Times
    by Daniel S. Levine
    September 15, 2006
 

Garage@UCSF Tenants


  • 100X Imaging

    100X Imaging builds advanced image automation software with applications in the life sciences. 100X Imaging's business model differs dramatically from existing companies because it supports and develops open source software. This approach removes many obstacles that scientists from the academic and private sector face with proprietary software. We believe that software for automated imaging can be deployed at lower cost and with increased transparency and reliability. 100X Imaging develops advanced, custom software solutions based on the existing open source platform micro-manager and on its extensive in-house expertise in many diverse areas of automated imaging.

  • Allopartis Biotechnologies

    Allopartis is a biofuel industry company focused on providing technologies for improving the efficiency and decreasing the cost for converting sustainable biomass products into clean-burning fuels.

  • Lypro Biosciences, Inc.

    Lypro is a company that uses nanoscale particles bound by high density lipoprotein to improve drug delivery.

  • Omniox Inc.

    Omniox is a biotechnology company commercializing a revolutionary and proprietary oxygen delivery technology for a broad range of clinical indications in cancer, surgical and cardiovascular markets. Omniox’s biotherapeutic platform was developed at the University of California, Berkeley by a team of outstanding scientists who have engineered a new class of oxygen delivery vehicles with properties that can be exploited for a range of clinical applications. Omniox was founded to translate these vehicles into focused therapeutics.

  • Simprota Corporation

    Simprota is a biotech company based in San Francisco, California, founded in 2006. We apply computer-aided modeling to peptides and proteins, to understand their mechanisms of action and to aid in the design of new therapeutics, diagnostics, and materials. Our proprietary technology utilizes physical-principles-based modeling in conjunction with fast conformational sampling. We provide novel ways to accelerate innovation in the pharmaceutical and biotechnology industries.